Intraoperative assessment of mitral valve and peri-operative results of surgical treatment of mitral valve disease in patients who previously underwent closed surgical and percutaneous transluminal mitral commissurotomy.
BACKGROUND
Surgical open or closed mitral commisurotomy and percutaneous transluminal mitral commissurotomy (PTMC) are the well-established therapies in patients with mitral valve stenosis. However, due to various factors the long-term effects may not be optimal in some patients, so they should undergo surgical mitral valve replacement.


OBJECTIVE
The intra-operative assessment of the morphology of mitral valve and the evaluation of the peri-operative results of surgical treatment in patients with mitral valve disease who previously underwent closed surgical commissurotomy followed by PTMC.


METHODS
Twenty one patients (20 males, mean age 49 years) who underwent surgery due to mitral valve disease after closed mitral commissurotomy and PTMC, are presented. The time from closed mitral commissurotomy to PTMC was 3-42 years, and the time from PTMC to mitral valve replacement - 9 days to almost 9 years.


RESULTS
One patient died on the second day after the operation because of left ventricular failure. The outcome of the remaining patients was good. Advanced changes of the mitral valve and subvalvular apparatus were present in the majority of patients.


CONCLUSIONS
The results of the implantation of mitral valve prosthesis in patients who previously underwent closed surgical mitral commissurotomy and PTMC are good. In some patients with a history of closed surgical mitral commissurotomy, PTMC delays surgical replacement of the mitral valve. Advanced changes in the mitral valve leaflets and subvalvular apparatus are the causes of PTMC failure.
Dyk
Wojciech
W
1st Department of Cardiac Surgery, National Institute of Cardiology, Warsaw, Poland.
Hendzel
Piotr
P
Chmielak
Zbigniew
Z
Juraszyński
Zbigniew
Z
Kotliński
Zbigniew
Z
Giec-Kowalewska
Maria
M
D000328:Adult; D000368:Aged; D002404:Catheterization / Q000379:methods*; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation*; D006801:Humans; D007432:Intraoperative Period; D008297:Male; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000473:pathology / Q000601:surgery*; D019990:Perioperative Care; D012086:Reoperation; D013997:Time Factors; D016896:Treatment Outcome